Home›Companies›Healthcare›Accuryn Medical

Potrero Medical, Inc.

Medical monitoring systems help clinicians track critically ill patients' kidney function.

Updated Nov 10, 2026·Latest SEC filing May 29, 2026·Suggest an edit

About Accuryn Medical

Accuryn Medical is a private company based in Hayward, California. It has reported $82,713,026 raised in eight offerings on Form D since May 2014. Its chief executive is Todd Dunn.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 8, 2026May 29, 2026$6,500,000fully sold56$116KEquityRule 506(c)Form D ↗
Aug 28, 2025Sep 2, 2025$2,278,241of $5.5M target29$78,560EquityRule 506(b)Form D ↗
Oct 24, 2024Oct 31, 2024$3,200,000of $12.0M target6$533KEquityRule 506(b)Form D ↗
Mar 24, 2023Apr 10, 2023$17,747,111of $24.6M target99$179KEquityRule 506(b)Form D ↗
Jun 28, 2019Jul 12, 2019amended Oct 29, 2019$17,185,962of $19.9M target26$660KEquityRule 506(b)Form D/A ↗1 earlier filing
May 25, 2018Jul 10, 2018$24,642,458of $31.3M target32$770KEquityRule 506(b)Form D ↗
Aug 30, 2016Sep 13, 2016amended Aug 7, 2017$7,259,254of $12.0M target21$345KEquityRule 506(b)Form D/A ↗1 earlier filing
May 13, 2014May 27, 2014$3,900,000fully sold9$433KEquityRule 506(c)Form D ↗
Total, eight offerings$82,713,026

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Accuryn Medical's Form D filed May 29, 2026.

RR
Ram Reddy
Director
Rich Keenan
Rich Keenan
Sr. Regional Vice President of Sales
Maurice Ferre
Maurice Ferre
Director
Also a director at Dermasensor and MIVI Neuroscience.
MS
Mike Stansky
Director
DM
David Matlin
Director
Also a director at Dermasensor.
Khalid Ghafari
Khalid Ghafari
Chief Financial Officer
Christopher Dewey
Christopher Dewey
Executive Chairman
Also a director at Dermasensor, MIVI Neuroscience and Radom.
CH

Earlier filings also listed Ramachandra Reddy (director, last listed Sep 2025), Chad Zaring (director, last listed Sep 2025), Sanjay Banerjee (chief executive officer, last listed Oct 2024), Joe Urban (president and ceo, director, last listed Apr 2023), Daniel Burnett (director, last listed Apr 2023), Colby Wood (director, last listed Apr 2023), Andrew Offer (director, last listed Apr 2023) and Alan Chesler (director, last listed Apr 2023).

Sources

  1. SECPotrero Medical, Inc. Form D, filed Jul 12, 2019
  2. SECPotrero Medical, Inc. Form D, filed Sep 13, 2016
  3. SECPotrero Medical, Inc. filing history
  4. CompanyPrivacy policy
  5. CompanyLeadership
  6. PressAccuryn Medical restructuring announcement
  7. PressPotrero Medical Series C announcement